Matches in DBpedia 2014 for { <http://dbpedia.org/resource/SIB-1757> ?p ?o. }
Showing items 1 to 32 of
32
with 100 items per page.
- SIB-1757 abstract "SIB-1757 is a drug used in scientific research which was one of the first compounds developed that acts as a selective antagonist for the metabotropic glutamate receptor subtype mGluR5. It has anti-hyperalgesia effects in animals. SIB-1757 along with other mGluR5 antagonists has been shown to have neuroprotective and hepatoprotective effects, and it is also used to study the role of the mGluR5 receptor in brain development.".
- SIB-1757 casNumber "31993-01-8".
- SIB-1757 iupacName "6-methyl-2-(phenylazo)-3-pyridinol".
- SIB-1757 pubchem "6849066".
- SIB-1757 thumbnail SIB-1757_structure.png?width=300.
- SIB-1757 wikiPageID "23625672".
- SIB-1757 wikiPageRevisionID "593046201".
- SIB-1757 c "12".
- SIB-1757 casNumber "31993".
- SIB-1757 h "11".
- SIB-1757 hasPhotoCollection SIB-1757.
- SIB-1757 iupacName "6".
- SIB-1757 molecularWeight "213.235".
- SIB-1757 n "3".
- SIB-1757 o "1".
- SIB-1757 pubchem "6849066".
- SIB-1757 smiles "Oc1cccnc1\N=N\c2ccccc2".
- SIB-1757 verifiedrevid "417966671".
- SIB-1757 width "200".
- SIB-1757 subject Category:Azo_compounds.
- SIB-1757 subject Category:Pyridines.
- SIB-1757 type Drug.
- SIB-1757 type DrugProduct.
- SIB-1757 type FunctionalSubstance.
- SIB-1757 comment "SIB-1757 is a drug used in scientific research which was one of the first compounds developed that acts as a selective antagonist for the metabotropic glutamate receptor subtype mGluR5. It has anti-hyperalgesia effects in animals. SIB-1757 along with other mGluR5 antagonists has been shown to have neuroprotective and hepatoprotective effects, and it is also used to study the role of the mGluR5 receptor in brain development.".
- SIB-1757 label "SIB-1757".
- SIB-1757 sameAs m.06zk337.
- SIB-1757 sameAs Q7390271.
- SIB-1757 sameAs Q7390271.
- SIB-1757 wasDerivedFrom SIB-1757?oldid=593046201.
- SIB-1757 depiction SIB-1757_structure.png.
- SIB-1757 isPrimaryTopicOf SIB-1757.
